Concepedia

Publication | Closed Access

RELEVENT Trial: Phase II Trial of Ramucirumab, Carboplatin, and Paclitaxel in Previously Untreated Thymic Carcinoma/B3 Thymoma With Area of Carcinoma

22

Citations

11

References

2018

Year

References

YearCitations

Page 1